# Yolanda Perez Saez

> Yolanda Perez Saez is a seed investor at Banco Sabadell backing Medical and Health Care. See 13 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Banco Sabadell](https://shizune.co/investors/profile/banco-sabadell)
- Location: Barcelona, Spain
- Total investments: 13
- Last investment: Apr 2024
- Lead investor: 62%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/yolanda-p%C3%A9rez-s%C3%A1ez-1421176/?originalSubdomain=es

Yolanda Perez Saez is a seed investor at Banco Sabadell in Barcelona focused on Medical and Health Care. Yolanda Perez Saez is the BStartup Director at Banco Sabadell.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 5 | 38% |
| Health Care | 4 | 31% |
| Biotechnology | 3 | 23% |
| Therapeutics | 2 | 15% |
| Medical Device | 2 | 15% |

20 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 5 | 38% |
| Funding Round | 4 | 31% |
| Pre-Seed | 3 | 23% |
| Venture - Series Unknown | 1 | 8% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Spain | 10 | 77% |
| United States | 1 | 8% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Emely AI | Emily.AI enables the adaptation to various environments and patient conditions, reducing or eliminating the need for medical supervision. The company has developed an oxygen therapy medical device that uses artificial intelligence to dynamically adjust to each patient's specific needs. | $511.6K | Pre-Seed | Apr 13, 2024 |  |
| Ocean Ecostructures | Ocean Ecostructures is the developer of a biodiversity regeneration program that will assist businesses and governments in transitioning to a blue economy. | $1.7M | Seed | Nov 23, 2023 |  |
| Epinium | Bestselling on Amazon | $549K |  | May 31, 2023 |  |
| Epinium | Bestselling on Amazon | $534.7K | Pre-Seed | May 31, 2023 |  |
| Oniria Therapeutics | Onira Therapeutics is modifying cell dormancy to fight the persistence of cancer. | $1.4M | Seed | May 11, 2023 |  |
| Doppli | Doppli connects future moms with their babies anytime, anywhere, allowing continuous monitoring of pregnancy. | $121.2K | Seed | Jan 28, 2021 |  |
| MiWendo | MiWendo is a medical device that integrates microwave technology with colonoscopy in order to improve the prevention, diagnosis, and knowledge of colorectal cancer. | $106K |  | Jan 28, 2021 |  |
| OXOlife | Oxolife is a biotech startup focused in R&D of reproductive efficiency and infertility treatments Oxolife (was founded in January 2013 by an entrepreneurial and multidisciplinary team formed biochemists and clinical Pharmacologist, with more than 10 year of expertise in R&D and pharmaceutical market. | $121.2K | Venture - Series Unknown | Jan 28, 2021 |  |
| INBRAIN Neuroelectronics | INBRAIN Neuroelectronics is pioneering real time precision neurology with the world’s first graphene-based brain-computer interface (BCI) therapeutics platform. Our technology combines precise BCI decoding with micrometric modulation to deliver adaptive, personalized treatments for conditions such as Parkinson’s disease, epilepsy, and strokerehabilitation. By providing continuous real-time monitoring and autonomous therapy adjustments, our AI-driven platform maximizes therapeutic outcomes while minimizing side effects. Through strategic collaborations, including with Merck KGAa and our subsidiary INNERVIA Bioelectronics, we are extending our innovative solutions to peripheral nerve and systemic disease applications, unlocking the potential of neurotechnology and bioelectronics. For more information, visit www.inbrain-neuroelectronics.com and follow us on LinkedIn. | $121.2K | Seed | Jan 28, 2021 |  |
| DIVE Medical | DIVE is a digital medical device that provides a fast and accurate exploration of the visual function in non-collaborative patients. It is specially designed to help pediatric ophthalmologists and pediatricians explore vision in children, including infants from six months of age and children with developmental issues. Using eye tracking technology,it provides an accurate, objective, and fast visual assessment to enable early diagnosis and treatment. |  |  | Jan 13, 2021 |  |

10 of 13 investments shown.

## Co-investors
- [CECOP](https://shizune.co/investors/profile/cecop-1963) — VC Fund, 1 deal together
- [JME Ventures](https://shizune.co/investors/profile/fundacin-jos-manuel-entrecanales) — VC Fund, 1 deal together
- [Fundacion Botin](https://shizune.co/investors/profile/fundacion-botin) — VC Fund, 1 deal together
- [IESE BAN](https://shizune.co/investors/profile/iese-ban) — VC Fund, 1 deal together
- [Inclimo Climate Tech Fund](https://shizune.co/investors/profile/inclimo-climate-tech-fund) — VC Fund, 1 deal together
- [Investigo](https://shizune.co/investors/profile/investigo-4fd0) — VC Fund, 1 deal together

## About Banco Sabadell

VC Fund · Alicante, Spain

Banco Sabadell is a banking group that specializes in serving small and medium enterprises. It comprises of several banks, brands, subsidiaries, and associated banks. The company was founded in 1881 and is headquartered in Alicante, Spain.

5 contacts available at Banco Sabadell.

| Name | Title | Profile |
| --- | --- | --- |
| Yolanda Perez Saez | Banco Sabadell | https://shizune.co/investors/profile/yolanda-p%C3%A9rez |
| Adolfo Hernandez | Head of Advanced Cyber Defense | https://shizune.co/investors/profile/adolfo-hern%C3%A1ndez |
| Aleix Escassi | Director of Customer & Business Development | https://shizune.co/investors/profile/aleix-escassi |
| Alfonso Ayuso | Subdirector General - Chief Innovation Officer | https://shizune.co/investors/profile/alfonso-ayuso |
| Jaime Guardiola | CEO | https://shizune.co/investors/profile/jaime-guardiola |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Yolanda Perez Saez invest in?

Yolanda Perez Saez invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed and Funding Round stage. Most of the 13 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Yolanda Perez Saez last invest?

The most recent investment recorded for Yolanda Perez Saez closed in Apr 2024. Shizune tracks 13 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co